Author:
Rolli F. R.,Ruggeri M.,Kheiraoui F.,Drago C.,Basile M.,Favaretti C.,Cicchetti A.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference31 articles.
1. WHO: Global health sector strategy on viral hepatitis, 2016–2021. WHO, Geneva (2016)
2. Razavi, H., El Khoury, A.C., Elbasha, E., et al.: Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology (Baltimore) 57, 2164–2170 (2013)
3. Poynard, T., Ratziu, V., Benmanov, Y., Di Martino, V., Bedossa, P., Opolon, P.: Fibrosis in patients with hepatitis C: detection and significance. Semin. Liver Dis. 20(1), 0047–0056 (2000)
4. Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., Razavi, H.: Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61(1 Suppl), S45–S57 (2014)
5. Marcellusi, A., Viti, R., Capone, A., Mennini, F.S.: The economic burden of HCV-induced diseases in Italy: a probabilistic cost of illness model. Eur. Rev. Med. Pharmacol. Sci. 19, 1610–1620 (2015)
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献